Earnings spark selloff: Social media chatter intensified after Oracle's recent quarterly results showed solid revenue growth but highlighted aggressive capital spending plans for AI infrastructure. Analysts and investors noted the company's substantial backlog expansion amid broader market highs. This fueled a sharp price decline from June peaks.
Capex concerns mount: Discussions centered on the scale of debt and equity raises needed to fund data center builds, with many expressing fatigue over the financing burden despite strong AI demand signals. The stock's prolonged decline drew comparisons to prior cycles of heavy investment. Sentiment reflected worries about dilution risks in the near term.
AI backlog draws focus: Optimism persisted around the massive contracted backlog tied to cloud growth, positioning Oracle as a key player in the expanding AI ecosystem. Users highlighted long-term revenue projections while acknowledging execution hurdles. Overall views remained mixed as the market weighs funding challenges against future potential.
Note: This discussion summary was generated from an AI condensation of post data.
Oracle Corporation Insider Trading Activity
Oracle Corporation insiders have traded $ORCL stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:
- JEFFREY HENLEY (Vice Chairman) has made 0 purchases and 11 sales selling 400,000 shares for an estimated $63,664,039.
- DOUGLAS A KEHRING (EVP, Principal Financial Offcr) sold 35,000 shares for an estimated $6,821,149
- STUART LEVEY (EVP, Chief Legal Officer) sold 15,000 shares for an estimated $2,642,850
- CLAYTON M. MAGOUYRK (Chief Executive Officer) sold 10,000 shares for an estimated $1,552,318
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Oracle Corporation Revenue
Oracle Corporation had revenues of $19.2B in Q4 2026. This is an increase of 20.63% from the same period in the prior year.
You can track ORCL financials on Quiver Quantitative's ORCL stock page.
You can access data on ORCL stock through the Quiver Quantitative API.
Oracle Corporation Congressional Stock Trading
Members of Congress have traded $ORCL stock 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:
- SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 05/07.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 03/23.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/30 and 1 sale worth up to $15,000 on 02/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
Oracle Corporation Hedge Fund Activity
We have seen 1,503 institutional investors add shares of Oracle Corporation stock to their portfolio, and 1,669 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 6,391,444 shares (-21.8%) from their portfolio in Q1 2026, for an estimated $913,912,577
- BNP PARIBAS FINANCIAL MARKETS added 4,942,597 shares (+123.5%) to their portfolio in Q1 2026, for an estimated $706,741,945
- BLACKROCK, INC. removed 4,548,275 shares (-3.1%) from their portfolio in Q1 2026, for an estimated $650,357,842
- CARDANO RISK MANAGEMENT B.V. removed 4,475,051 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $639,887,542
- COATUE MANAGEMENT LLC removed 4,440,008 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $634,876,743
- BANK OF MONTREAL /CAN/ removed 3,822,912 shares (-46.7%) from their portfolio in Q1 2026, for an estimated $546,638,186
- DEFIANCE ETFS, LLC added 3,048,953 shares (+1113.1%) to their portfolio in Q1 2026, for an estimated $435,969,789
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Oracle Corporation Government Contracts
We have seen $1,685,848,944 of award payments to $ORCL over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EHRM WAVES K, L, M (VISN 23) AND N, O (VISN 15) DEPLOYMENTS: $775,682,055
- EHRM OPERATIONS: $267,237,965
- IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES...: $220,337,868
- EHRM LICENSES AND FEES: $133,449,794
- FORMALLY RECOGNIZE THE CONTRACTORS CORPORATE NAME CHANGE FROM CERNER GOVERNMENT SERVICES INC. TO ORACLE HEA...: $94,734,522
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
Oracle Corporation Analyst Ratings
Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/03/2026
To track analyst ratings and price targets for Oracle Corporation, check out Quiver Quantitative's $ORCL forecast page.
Oracle Corporation Price Targets
Multiple analysts have issued price targets for $ORCL recently. We have seen 28 analysts offer price targets for $ORCL in the last 6 months, with a median target of $247.5.
Here are some recent targets:
- Mark L. Moerdler from Bernstein set a target price of $325.0 on 06/11/2026
- Billy Fitzsimmons from Piper Sandler set a target price of $225.0 on 06/11/2026
- Thomas Blakey from Cantor Fitzgerald set a target price of $284.0 on 06/11/2026
- Raimo Lenschow from Barclays set a target price of $250.0 on 06/11/2026
- Derrick Wood from TD Cowen set a target price of $300.0 on 06/11/2026
- Rishi Jaluria from RBC Capital set a target price of $190.0 on 06/11/2026
- Keith Bachman from BMO Capital set a target price of $220.0 on 06/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
